LIFELABS GENETICS
LIVE

Serial Number

87246841

Owner

LIFELABS LP

Attorney

Nicholas G. de la Torre

Filing Date

Nov 23, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LIFELABS GENETICS Trademark

Serial Number: 87246841 • Registration: 6311559

LIFELABS GENETICS is a trademark filed by LIFELABS LP on November 23, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

LIFELABS LP (12 trademarks)

100 INTERNATIONAL BLVD; 1ST FLOOR
TORONTO, ONTARIO M9W 6J6 , CA

Entity Type: 13

Trademark Details

Filing Date

November 23, 2016

Registration Date

April 6, 2021

Published for Opposition

August 4, 2020

Goods & Services

drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of lipids, carbohydrates, proteins, enzymes, acids, alcohols, metabolites, vitamins, electrolytes, heavy metals, contaminants, poisons, and toxins; diagnostic, preparations for medical research use; medical diagnostic reagents; diagnostic kits comprised of organic and inorganic medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; biological preparations for detecting genetic predispositions for medical purposes; newborn screenings, namely, genetic identity tests comprised of reagents for medical purposes; newborn screenings, namely, preparations for detecting somatic mutation in genes for medical purposes; newborn screenings, namely, preparations for detecting autoimmune diseases in genes for medical purposes; newborn screenings, namely, preparations for detecting epigenetic disorders in genes for medical purposes; newborn screenings, namely, medical diagnostic test strips for blood analysis; diagnostic biomarker reagents for analysis of genetic sequencing for medical purposes; diagnostic biomarker reagents for analysis of metabolic disorders for medical purposes; diagnostic biomarker reagents for analysis of enzyme deficiency for medical purposes

chemically treated non-medical test strips for calibration of laboratory test equipment and medical diagnostic equipment; diagnostic preparations for medical laboratory use; diagnostic reagents for clinical and medical laboratory use; assays and reagents for use in genetic research; genetic identity tests comprised of reagents for non-medical purposes; reagents for scientific or medical research use; chemical reagents for non-medical purposes

medical research consulting; design and development of computer hardware and software for genetic testing, genetic sequencing, biochemical analysis, newborn screening and data processing; laboratory research in the fields of biochemistry and medical genetics; laboratory testing of materials; medical laboratory services; blood analysis services; DNA analysis services for scientific research purposes; providing medical research information in the field of patient clinical trials; providing an interactive web site featuring technology that enables users to access, monitor and generate medical information and reports; providing information relating to pharmacology consultancy

providing access to an electronic exchange of medical records across a nationwide health information network to enable physicians to make informed medical recommendations

consulting services in the field of genetic testing for medical purposes; consulting services in the field of medical testing for diagnostic purposes; consulting services in the field of medical screening of infants for hereditary medical disorders; medical analysis services for diagnostic and medical purposes, namely, medical analysis of, blood, body fluids, extracellular tissue specimens, stool samples, exhaled air, biopsy specimens and autopsy specimens; Medical laboratory testing of blood, body fluids, extracellular tissue specimens, stool samples, exhaled air, biopsy specimens and autopsy specimens all for diagnostic and medical purposes; medical information services, namely, reporting of patient authorized clinical testing results directly to doctors; medical analysis services of patient medical data for the diagnosis of cancer; providing medical information to doctors in the form of reports in the field of a medical diagnosis; providing healthcare information; providing medical information to patients in the field of pharmaceutical treatments; providing information relating to diagnostic properties of pharmaceuticals; providing medical information; providing health information to physicians about surgical instruments

Aliquotters, namely, manual and robotic devices for use in medical laboratories to accurately dispense liquid volumes of medical patient samples and reagents into separate specimen containers; filters for blood and blood components for laboratory use; laboratory devices implementing nucleic acid extraction, fluorescence in situ hybridization and competitive hybridization to detect genetic sequences; scientific instruments, namely, analyzers for detecting and karyotyping chromosomes; computer software for scientific analysis of genetic sequences; computer software platform for analyzing bioinformatics to interpret results of genetic testing; computer software platforms for use in generating clinical reports for genetic testing; computer communications software for connecting medical practices via the Internet to manage and share patient information relating to genetic testing orders and results; computer programs for managing requests for genetic testing, laboratory processing and laboratory equipment; computer programs for controlling quality of testing and integrity of testing results

data processing services; customer services, namely, responding to customers inquiries for others in the field of medical laboratory services; customer services, namely, responding to customers inquiries for others in the field of medical diagnostic services

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 6, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 27, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 6, 2021 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Mar 4, 2021 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 4, 2021 AITU
NOTICE OF ALLOWANCE CANCELLED
Nov 22, 2020 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Nov 22, 2020 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 29, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 26, 2020 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2019 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 14, 2019 ZZZX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 13, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 13, 2019 REAP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 10, 2019 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2019 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 12, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 27, 2019 ERSI
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 26, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 28, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 28, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 28, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 27, 2018 RCCK
ASSIGNED TO LIE
Sep 27, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 7, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 7, 2018 GNSL
SUSPENSION LETTER WRITTEN
Mar 7, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 13, 2018 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 7, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 7, 2017 GNSL
SUSPENSION LETTER WRITTEN
Nov 7, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 16, 2017 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 22, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 22, 2017 GNSL
SUSPENSION LETTER WRITTEN
Sep 22, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 2, 2016 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2016 NWOS
NEW APPLICATION ENTERED
Nov 26, 2016 NWAP